Form 4: Actuate Therapeutics Insider Ownership Update: Kreis and Related Entities Report Beneficial Ownership
SEC Form 4
Leslie W. Kreis, along with associated entities including BIOS Equity Partners, reported changes in beneficial ownership of Actuate Therapeutics, Inc. common stock.
Summary
- Leslie W. Kreis, a director of Actuate Therapeutics, Inc., and related entities filed a Form 4 detailing their beneficial ownership of the company's common stock.
- The reporting entities include Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, Bios Equity Partners, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, and Bios Equity Partners II, LP.
- Kreis indirectly holds 84,917 shares through BP Directors, LP, 69,375 shares through Circle K Invesco, LP, and other shares through various trusts and entities.
- The filing indicates that these entities may be deemed 'directors by deputization' due to Aaron G.L. Fletcher's position as a director of the Issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure required by the SEC for individuals and entities with significant ownership in publicly traded companies. It provides transparency into insider ownership and potential influence.
Stakeholder Impact
- Shareholders are informed about the ownership structure and potential influence of key individuals and entities.
- The filing provides transparency to the market regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 2016-12-07 | Date of KF Legacy Trust U/A/D and MF Legacy Trust U/A/D |
| 2024-08-12 | Date of earliest transaction reported |
| 2024-08-14 | Date of signature for the Form 4 filings |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.